- Home
- OPK vs NFJ Comparison
OPK vs NFJ Comparison
Compare OPK & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- NFJ
- Stock Information
- Founded
- OPK 2007
- NFJ 2005
- Country
- OPK United States
- NFJ United States
- Employees
- OPK N/A
- NFJ N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- OPK Health Care
- NFJ Finance
- Exchange
- OPK Nasdaq
- NFJ Nasdaq
- Market Cap
- OPK 1.3B
- NFJ 1.2B
- IPO Year
- OPK 1995
- NFJ N/A
- Fundamental
- Price
- OPK $1.66
- NFJ $12.12
- Analyst Decision
- OPK Strong Buy
- NFJ
- Analyst Count
- OPK 3
- NFJ 0
- Target Price
- OPK $2.75
- NFJ N/A
- AVG Volume (30 Days)
- OPK 4.1M
- NFJ 223.5K
- Earning Date
- OPK 05-06-2025
- NFJ 01-01-0001
- Dividend Yield
- OPK N/A
- NFJ 9.01%
- EPS Growth
- OPK N/A
- NFJ N/A
- EPS
- OPK N/A
- NFJ N/A
- Revenue
- OPK $713,142,000.00
- NFJ N/A
- Revenue This Year
- OPK N/A
- NFJ N/A
- Revenue Next Year
- OPK $6.25
- NFJ N/A
- P/E Ratio
- OPK N/A
- NFJ N/A
- Revenue Growth
- OPK N/A
- NFJ N/A
- 52 Week Low
- OPK $1.15
- NFJ $10.45
- 52 Week High
- OPK $2.04
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- OPK 40.64
- NFJ 39.22
- Support Level
- OPK $1.75
- NFJ $12.07
- Resistance Level
- OPK $1.80
- NFJ $12.26
- Average True Range (ATR)
- OPK 0.06
- NFJ 0.15
- MACD
- OPK -0.03
- NFJ 0.01
- Stochastic Oscillator
- OPK 8.70
- NFJ 61.36
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.